CRISPR Therapeutics stays a Hold as CASGEVY launch lags; watch cash burn, revenue delays, and CTX310/CTX611 catalysts for ...

Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...

Today’s Forbes Daily also covers Anthropic’s hot streak, a junk bond master, Les Wexner’s upcoming Epstein deposition, cutting edge bobsled engineering and more.

Study in Science Advances shows proprietary Spherical Nucleic Acid (SNA) vaccine platform slows tumor growth and extends survival in preclinical models of HPV-related cancerEVANSTON, Ill.--(BUSINESS ...

ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial ...

CRISPR Therapeutics AG CRSP on Friday reported its fourth-quarter and full-year 2025 financial results, highlighting continued clinical progress, expanding uptake of Casgevy, and momentum across its ...

Oceanic ecosystems are increasingly threatened by global warming, which causes coral bleaching, species migration and, ...

Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...

Oral diseases are a significant global health issue, affecting both quality of life and overall systemic health. Animal ...

The 26 students from the U.S have been selected as Gates Cambridge Scholars for 2026. They will begin their graduate studies ...

Muscles make up nearly 40% of the human body and power every move we make, from a child's first steps to recovery after ...

The Vilcek Foundation is now accepting applications for the 2027 Vilcek Prizes for Creative Promise in Biomedical Science through May 4, 2026. These $50,000 cash awards are given each year to three ...